FDA Approves Autoinjector Pen for Humira Biosimilar, Cyltezo FDA Approves Autoinjector Pen for Humira Biosimilar, Cyltezo

The drug will be commercially available on July 1, 2023.Medscape Medical News

Source: Medscape Allergy Headlines - May 22, 2023 Category: Allergy & Immunology Tags: Rheumatology News Alert Source Type: news